Du Hongmei, Zhou Yuan, Wang Jia, Bai Xianbing, Tao Borui, Chen Ming
Department of Pharmacology, School of Basic Medical Sciences, Anhui Medical University, No.81 Meishan Road, Hefei, 230032, China.
Department of Pharmacy, Lu'an Hospital of Anhui Medical University (Lu'an People's Hospital of Anhui Province), Lu'an, 237121, China.
Psychopharmacology (Berl). 2025 May 28. doi: 10.1007/s00213-025-06820-z.
Patients with non-alcoholic fatty liver disease (NAFLD) may experience non-cognitive impairments such as anxiety and depression. However, the specific mechanism of the association between liver injury and neurological disorders is unclear.
In this study, we aimed to explore the relationship and underlying mechanism between high-fat fructose diet (HFFD)-induced liver injury and anxiety-like behavior in mice.
A mouse model of NAFLD was established using an HFFD, and behavioral tests were performed to detect anxiety-like behaviors in mice; moreover, we used enzyme linked immunosorbent assay (ELISA) to detect glutamate levels in treated and normal diet (ND) mice, as well as to explore inflammation levels in mice using immunofluorescence and other methods.
Mice in the HFFD-treated group exhibited anxiety-like behaviors, as well as elevated serum lipid and glutamate levels, increased liver injury, and hepatic tissue fat accumulation. Additionally, HFFD-fed mice exhibited elevated levels of IL-6, IL-1β, and TNF-α in the liver, hippocampus, and cortex compared with the ND counterparts; HFFD-induced astrocyte and microglial activation was detected in the cortical and hippocampal regions. However, corilagin treatment alleviated these HFFD-associated pathological changes. Corilagin did not ameliorate anxiety behaviors in mice in the absence of liver injury.
Our results indicated that the HFFD-induced NAFLD and mild hepatic fibrosis led to elevated levels of glutamate and aminotransferases, which infiltrated the brain, causing inflammation, and subsequently induced anxiety-like behaviors in mice. These pathological and behavioral manifestations were ameliorated through corilagin intervention. This study provides a possible underlying mechanism between HFFD and neurological disorders.
非酒精性脂肪性肝病(NAFLD)患者可能会出现焦虑和抑郁等非认知功能障碍。然而,肝损伤与神经障碍之间关联的具体机制尚不清楚。
在本研究中,我们旨在探讨高脂果糖饮食(HFFD)诱导的肝损伤与小鼠焦虑样行为之间的关系及潜在机制。
使用HFFD建立NAFLD小鼠模型,并进行行为测试以检测小鼠的焦虑样行为;此外,我们使用酶联免疫吸附测定(ELISA)检测经处理的小鼠和正常饮食(ND)小鼠的谷氨酸水平,并使用免疫荧光和其他方法探索小鼠的炎症水平。
HFFD处理组的小鼠表现出焦虑样行为,以及血清脂质和谷氨酸水平升高、肝损伤增加和肝组织脂肪堆积。此外,与ND组相比,HFFD喂养的小鼠在肝脏、海马和皮质中IL-6、IL-1β和TNF-α水平升高;在皮质和海马区域检测到HFFD诱导的星形胶质细胞和小胶质细胞活化。然而,柯里拉京治疗减轻了这些与HFFD相关的病理变化。在没有肝损伤的情况下,柯里拉京并不能改善小鼠的焦虑行为。
我们的结果表明,HFFD诱导的NAFLD和轻度肝纤维化导致谷氨酸和转氨酶水平升高,它们渗入大脑,引起炎症,随后诱导小鼠出现焦虑样行为。这些病理和行为表现通过柯里拉京干预得到改善。本研究提供了HFFD与神经障碍之间可能的潜在机制。